New painkiller may cut opioid use after shoulder surgery
NCT ID NCT07410182
First seen Feb 16, 2026 · Last updated May 23, 2026 · Updated 13 times
Summary
This study tests if a long-acting version of a common painkiller works better than the standard version for pain after shoulder surgery. About 60 adults having arthroscopic shoulder surgery will receive one of the two medicines as a nerve block. The goal is to see if the long-acting version reduces the need for stronger opioid painkillers in the first three days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BUPIVACAINE are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.